Skip to main content

Table 4 Laboratory and neuroimaging

From: Intra-arterial application of nimodipine in reversible cerebral vasoconstriction syndrome: a neuroradiological method to help differentiate from primary central nervous system vasculitis

Laboratory analysis

 

ESR (mean ± standard deviation) (mm/h)

15/28 ± 8/14 (n = 4)

CRP abnormal (≥ 0.5 mg/dl), n (%)

2 (15.4)

Vasculitis parameters positive, n (%)

2 (25)

Abnormal CSF, n (%) 9 (81.8)

 

 Cell count (mean; median; range) (cells/mm3)

10.3; 8.5; 1–29 (n = 10)

 Protein concentration (mean; median, range) (mg/l)

456.4; 429.5; 363–604 (n = 8)

 Oligoclonal bands positive, n (%)

3 (27.3)

Neuroimaging, n (%)

 

Infarct

6 (46.2)

 Border zone infarct

2 (28.6)

 Territorial infarct

4 (57.1)

 Cerebellar infarct

1 (14.2)

Multiple infarcts

4 (30.8)

Microbleeds

1 (7.7)

Parenchymal hemorrhage

1 (7.7)

Subarachnoid hemorrhage

4 (30.8)

 Cortical localisation

3 (75)

Posterior reversible encephalopathy syndrome (PRES)

2 (15.4)

Abnormal CTA/MRA

6 (54.5)